The estimated Net Worth of Gregory Morrison is at least $5.66 Million dollars as of 10 November 2017. Gregory Morrison owns over 92,140 units of Wright Medical NV stock worth over $1,063,930 and over the last 9 years Gregory sold WMGI stock worth over $4,592,407.
Gregory has made over 6 trades of the Wright Medical NV stock since 2016, according to the Form 4 filled with the SEC. Most recently Gregory sold 92,140 units of WMGI stock worth $2,183,718 on 10 November 2017.
The largest trade Gregory's ever made was selling 92,140 units of Wright Medical NV stock on 10 November 2017 worth over $2,183,718. On average, Gregory trades about 16,141 units every 44 days since 2015. As of 10 November 2017 Gregory still owns at least 35,488 units of Wright Medical NV stock.
You can see the complete history of Gregory Morrison stock trades at the bottom of the page.
Gregory's mailing address filed with the SEC is 10801 NESBITT AVNEUE S., , BLOOMINGTON, MN, 55437.
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman und Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
Wright Medical NV executives and other stock owners filed with the SEC include: